Clinical Trial Update: Tirellizumab+Anlotinib VS Anlotinib for MSS-type CRC

View source ↗

Summary

A completed clinical trial comparing Tirellizumab plus Anlotinib versus Anlotinib alone in microsatellite-stable colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Anlotinib (anlotinib)
• Tirellizumab (Tirellizumab)

Snippet

Sponsor: fan li | Conditions: Colon Cancer, Immunotherapy | Status: COMPLETED